SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sabrina Thomann, Jan B. Boscheinen, Karin Vogel, David M. Knipe, Neal DeLuca, Stefanie Gross, Beatrice Schuler-Thurner, Philipp Schuster, Barbara Schmidt, Combined cytotoxic activity of an infectious, but non-replicative herpes simplex virus type 1 and plasmacytoid dendritic cells against tumour cells, Immunology, 2015, 146, 2
  2. 2
    Daniela Planska, Monika Burocziova, Jan Strnadel, Vratislav Horak, Immunohistochemical Analysis of Collagen IV and Laminin Expression in Spontaneous Melanoma Regression in the Melanoma-Bearing Libechov Minipig, Acta Histochemica et Cytochemica, 2015, 48, 1, 15

    CrossRef

  3. 3
    Abhishek D Garg, Hannelore Maes, Alexander R van Vliet, Patrizia Agostinis, Targeting the hallmarks of cancer with therapy-induced endoplasmic reticulum (ER) stress, Molecular & Cellular Oncology, 2015, 2, 1, e975089

    CrossRef

  4. 4
    Rossella Di Trolio, Ester Simeone, Giuseppe Di Lorenzo, Carlo Buonerba, Paolo Antonio Ascierto, The use of interferon in melanoma patients: A systematic review, Cytokine & Growth Factor Reviews, 2015, 26, 2, 203

    CrossRef

  5. 5
    Benedict Panizza, Timothy A. Warren, C. Arturo Solares, Glen M. Boyle, Duncan Lambie, Ian Brown, Histopathological features of clinical perineural invasion of cutaneous squamous cell carcinoma of the head and neck and the potential implications for treatment, Head & Neck, 2014, 36, 11
  6. 6
    Chiara Camisaschi, Viviana Vallacchi, Chiara Castelli, Licia Rivoltini, Monica Rodolfo, Immune cells in the melanoma microenvironment hold information for prediction of the risk of recurrence and response to treatment, Expert Review of Molecular Diagnostics, 2014, 14, 6, 643

    CrossRef

  7. 7
    Hansje-Eva Teulings, Karin J. Willemsen, Iris Glykofridis, Gabrielle Krebbers, Lisa Komen, Marije W. Kroon, E. Helen Kemp, Albert Wolkerstorfer, J. P. Wietze Veen, Rosalie M. Luiten, Esther P. M. Tjin, The antibody response against MART-1 differs in patients with melanoma-associated leucoderma and vitiligo, Pigment Cell & Melanoma Research, 2014, 27, 6
  8. 8
    Diwakar Davar, Ahmad A. Tarhini, John M. Kirkwood, Adjuvant immunotherapy of melanoma and development of new approaches using the neoadjuvant approach, Clinics in Dermatology, 2013, 31, 3, 237

    CrossRef

  9. 9
    T. Gambichler, M. Bindsteiner, S. Höxtermann, S. Terras, A. Kreuter, Circulating CD4+CD25highCD127low regulatory T cells are an independent predictor of advanced melanoma, Pigment Cell & Melanoma Research, 2013, 26, 2
  10. 10
    L. Benzekri, Y. Gauthier, S. Hamada, B. Hassam, Clinical features and histological findings are potential indicators of activity in lesions of common vitiligo, British Journal of Dermatology, 2013, 168, 2
  11. 11
    Y. Harmelin, N. Cardot-Leccia, J.-P. Ortonne, P. Bahadoran, J.-P. Lacour, T. Passeron, Localized depigmentation on genital melanosis: a clue for the understanding of vitiligo, British Journal of Dermatology, 2013, 168, 3
  12. 12
    Vicente Sabater Marco, Begoña Escutia Muñoz, Arturo Morera Faet, Manuel Mata Roig, Rafael Botella Estrada, Pseudogranulomatous Spitz nevus: a variant of Spitz nevus with heavy inflammatory infiltrate mimicking a granulomatous dermatitis, Journal of Cutaneous Pathology, 2013, 40, 3
  13. 13
    Anne Helene Køstner, Rakel Fuglesang Johansen, Henrik Schmidt, Ingolf Mølle, Regression in cancer following fever and acute infection, Acta Oncologica, 2013, 52, 2, 455

    CrossRef

  14. 14
    N. van Geel, R. Speeckaert, J. Lambert, I. Mollet, S. De Keyser, S. De Schepper, L. Brochez, Halo naevi with associated vitiligo-like depigmentations: pathogenetic hypothesis, Journal of the European Academy of Dermatology and Venereology, 2012, 26, 6
  15. 15
    L. Hoenicke, L. Zender, Immune surveillance of senescent cells--biological significance in cancer- and non-cancer pathologies, Carcinogenesis, 2012, 33, 6, 1123

    CrossRef

  16. 16
    Jože Pižem, Larisa Stojanovič, Boštjan Luzar, Melanocytic lesions with eczematous reaction (Meyerson's phenomenon) – a histopathologic analysis of 64 cases, Journal of Cutaneous Pathology, 2012, 39, 10
  17. 17
    M. Maio, Melanoma as a model tumour for immuno-oncology, Annals of Oncology, 2012, 23, suppl 8, viii10

    CrossRef

  18. 18
    N. van Geel, I. Mollet, L. Brochez, M. Dutré, S. De Schepper, E. Verhaeghe, J. Lambert, R. Speeckaert, New insights in segmental vitiligo: case report and review of theories, British Journal of Dermatology, 2012, 166, 2
  19. 19
    Joannes FM Jacobs, Stefan Nierkens, Carl G Figdor, I Jolanda M de Vries, Gosse J Adema, Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?, The Lancet Oncology, 2012, 13, 1, e32

    CrossRef